News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medgenisis Announces Issue of Options and Restricted Shares to Directors and Officers


1/9/2012 6:39:08 AM

MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announces that, pursuant to approvals given at a Board meeting held on 9 December 2011, on 3 January 2012 it (i) granted options to subscribe for 15,000 common shares (“Options”) and (ii) made a restricted share award of 7,000 common shares of par value US$0.0001 each (“Common Shares”) in the Company (“Restricted Shares”) to each of Isaac Blech, Gary Brukardt, Alastair Clemow, Joel Kanter, and Stephen McMurray, all non-executive directors of the Company, as part of their remuneration for the year.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES